Kodiak Sciences, Inc. (KOD)
41.98
-3.10
(-6.87%)
USD |
NASDAQ |
Apr 15, 16:00
42.08
+0.10
(+0.25%)
After-Hours: 20:00
Kodiak Sciences Research and Development Expense (Annual) : 182.37M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tango Therapeutics, Inc. | 129.88M |
| Eli Lilly & Co. | 13.34B |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| ADMA Biologics, Inc. | 4.762M |